Shanghai Singlera Genomics, a genetic early cancer screening company, has completed nearly RMB1 billion yuan in Series B financing.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
